The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of Dana-Farber Cancer Institute; Rashid K. Sayyid, MD, MSc, of the University of Toronto; and Reginald ...

Bristol Myers Squibb BMY recently obtained FDA approval for the label expansion of Breyanzi (lisocabtagene maraleucel) for ...

This blog is the last in a series about different psychological therapies. Fortunately for me, this one has a happy ending. Dialectical Behaviour Therapy: What is it? And what is it like to get DBT?

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...